Emergent BioSolutions Inc.

EBS · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$99,500$111,700$642,600$576,300
Short-Term Investments$0$0$0$0
Receivables$154,500$191,000$159,200$278,900
Inventory$311,700$328,900$350,700$344,500
Other Curr. Assets$33,000$47,900$57,900$70,200
Total Curr. Assets$598,700$679,500$1,210,400$1,269,900
Property Plant & Equip (Net)$270,600$399,000$837,000$828,400
Goodwill$0$0$218,200$224,900
Intangibles$501,500$566,600$728,800$604,600
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$18,900$178,100$171,900$29,900
Total NC Assets$791,000$1,143,700$1,955,900$1,687,800
Other Assets$0$0$0$0
Total Assets$1,389,700$1,823,200$3,166,300$2,957,700
Liabilities
Payables$60,900$112,200$103,500$128,900
Short-Term Debt$2,700$413,700$963,100$37,400
Tax Payable$0$0$0$0
Deferred Revenue$0$0$26,400$11,700
Other Curr. Liab.$98,800$125,400$135,900$196,000
Total Curr. Liab.$162,400$651,300$1,228,900$374,000
LT Debt$673,400$446,500$463,300$833,600
Deferred Rev, NC$0$0$0$4,700
Deferred Tax Liab, NC$41,700$0$59,700$93,300
Other NC Liab.$29,400$76,100$26,700$40,600
Total NC Liab.$744,500$522,600$549,700$972,200
Other Liabilities$0$0$0$0
Cap. Leases$9,700$0$14,800$24,200
Total Liabilities$906,900$1,173,900$1,778,600$1,346,200
Equity
Pref Stock$0$0$0$0
Common Stock$100$100$100$100
Retained Earnings-$212,400-$21,800$738,700$950,300
AOCI-$5,200-$5,700$3,100-$16,100
Other Equity$700,300$676,700$645,800$677,200
Total Equity$482,800$649,300$1,387,700$1,611,500
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,389,700$1,823,200$3,166,300$2,957,700
Net Debt$576,600$748,500$783,800$294,700